Status: current, Defined. Date: 31-May 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1923431000168115 | Revolade (eltrombopag 25 mg) powder for oral liquid, 30 x 25 mg sachets (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1923441000168112 | Revolade 25 mg powder for oral liquid, 30 sachets | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Revolade 25 mg powder for oral liquid, 30 sachets | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Revolade 25 mg powder for oral liquid, 30 sachets | Is a | Revolade 25 mg powder for oral liquid, 30 sachets | true | Inferred relationship | Some | ||
| Revolade 25 mg powder for oral liquid, 30 sachets | has TPUU | Revolade 25 mg powder for oral liquid, 25 mg sachet | true | Inferred relationship | Some | 1 | |
| Revolade 25 mg powder for oral liquid, 30 sachets | has container type | sachet | true | Inferred relationship | Some | ||
| Revolade 25 mg powder for oral liquid, 30 sachets | has TP | Revolade | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR